Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults., Journal of Consulting and Clinical Psychology, vol.68, issue.5, pp.748-766, 2000. ,
DOI : 10.1037/0022-006X.68.5.748
Conséquences sanitaires de la catastrophe AZF. http://www.invs.sante.fr/Dossiers-thematiques/Environnement-et-sante/Consequences-sanitaires-de-lacatastrophe-d-AZF (dernière consultation, 2014. ,
Psychosocial treatment of posttraumatic stress disorder, J Clin Psychiatry, vol.61, issue.5, pp.43-48, 2000. ,
Fluoxetine Versus Placebo in Posttraumatic Stress Disorder, The Journal of Clinical Psychiatry, vol.63, issue.3, pp.199-206, 2002. ,
DOI : 10.4088/JCP.v63n0305
Individual and Societal Effects of Mental Disorders on Earnings in the United States: Results From the National Comorbidity Survey Replication, American Journal of Psychiatry, vol.165, issue.6, pp.703-711, 2008. ,
DOI : 10.1176/appi.ajp.2008.08010126
The NIMH Epidemiologic Catchment Area Program, Archives of General Psychiatry, vol.41, issue.10, 1984. ,
DOI : 10.1001/archpsyc.1984.01790210016003
Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States, Archives of General Psychiatry, vol.51, issue.1, pp.8-19, 1994. ,
DOI : 10.1001/archpsyc.1994.03950010008002
Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication, Archives of General Psychiatry, vol.62, issue.6, pp.617-627, 2005. ,
DOI : 10.1001/archpsyc.62.6.617
High risk studies and developmental antecedents of anxiety disorders, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol.117, issue.2, pp.99-117, 2008. ,
DOI : 10.1002/ajmg.c.30170
Phenomenology and epidemiology of panic disorder, Ann Clin Psychiatry. juin, vol.21, issue.322, pp.95-102, 2009. ,
Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective Study, American Journal of Psychiatry, vol.162, issue.6, pp.1179-87, 2005. ,
DOI : 10.1176/appi.ajp.162.6.1179
Bon usage des médicaments dans le traitement des troubles dépressifs et des troubles anxieux de l'adulte ? argumentaire, 2006. ,
La prise en charge du trouble de panique ,
Double-Blind, Fixed-Dose, Placebo-Controlled Study of Paroxetine in the Treatment of Panic Disorder, American Journal of Psychiatry, vol.155, issue.1, pp.36-42, 1998. ,
DOI : 10.1176/ajp.155.1.36
A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder, Acta Psychiatrica Scandinavica, vol.26, issue.2, pp.145-52, 1997. ,
DOI : 10.1097/00004714-198710000-00007
Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism, Biological Psychiatry, vol.37, issue.2, pp.112-121, 1997. ,
DOI : 10.1016/0006-3223(94)00156-W
Role of 5-HT in stress, anxiety, and depression, Pharmacology Biochemistry and Behavior, vol.54, issue.1, pp.129-170, 1996. ,
DOI : 10.1016/0091-3057(95)02135-3
A Functional Subset of Serotonergic Neurons in the Rat Ventrolateral Periaqueductal Gray Implicated in the Inhibition of Sympathoexcitation and Panic, Annals of the New York Academy of Sciences, vol.113, issue.1, 2004. ,
DOI : 10.1196/annals.1296.006
Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder, Biological Psychiatry, vol.61, issue.9, pp.1081-1090, 2007. ,
DOI : 10.1016/j.biopsych.2006.05.022
Effect of ??-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial, Nutrition, vol.21, issue.6, pp.705-715, 2005. ,
DOI : 10.1016/j.nut.2004.07.020
The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra, Biol Psychiatry, vol.16, issue.759, pp.837-50, 1981. ,
Magnesium Attenuates Post-Traumatic Depression/Anxiety Following Diffuse Traumatic Brain Injury in Rats, Journal of the American College of Nutrition, vol.47, issue.5, pp.529-533, 2004. ,
DOI : 10.1080/07315724.2004.10719396
The SU.VI.MAX Study, Archives of Internal Medicine, vol.164, issue.21, pp.2335-2377, 2004. ,
DOI : 10.1001/archinte.164.21.2335
URL : https://hal.archives-ouvertes.fr/hal-01346671
INDUCED THIAMINE (VITAMIN B1) DEFICIENCY IN MAN, Archives of Internal Medicine, vol.71, issue.1, pp.38-53, 1983. ,
DOI : 10.1001/archinte.1943.00210010044003
Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity, Journal of Epidemiology & Community Health, vol.61, issue.7, pp.631-638, 2007. ,
DOI : 10.1136/jech.2006.050385
Treatment of depression: time to consider folic acid and vitamin B12, Journal of Psychopharmacology, vol.19, issue.1, pp.59-65, 2005. ,
DOI : 10.1177/0269881105048899
Folate for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials, Journal of Psychopharmacology, vol.18, issue.2, pp.251-257, 2004. ,
DOI : 10.1177/0269881104042630
(dernière consultation : janvier 2015) (91) Le tryptophane http://a54.idata.over-blog, 2015. ,
The impact of selenium supplementation on mood, Biological Psychiatry, vol.29, issue.11, pp.1092-1100, 1991. ,
DOI : 10.1016/0006-3223(91)90251-G
Rollnick S., l'entretien motivationnel : aider la personne à engager le changement ,
Therapeutic patient education ,
Syndrome sérotoninergique et interactions médicamenteuses, Pharma- Flash, pp.15-20, 2006. ,
Allégations nutritionnelles http://www.mangerbouger.fr/bien-manger/infos-nutritionnelles/allegations-nutritionnelles-sur-lesproduits .html (dernière consultation, 2015. ,
Omega-3 fatty acids administered in phosphatidylserine improved certain aspects of high chronic stress in men, Nutrition Research, vol.32, issue.4, pp.241-50, 2012. ,
DOI : 10.1016/j.nutres.2012.03.003
The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression, Psychopharmacology, vol.171, issue.3, pp.286-97, 2004. ,
DOI : 10.1007/s00213-003-1586-8
oméga 3 » : si la teneur en acide alpha-linolénique (ALA) est supérieure ou égale à 0,3 g pour 100 g, 100 ml ou 100 kcal ou si la teneur en acide docosahexaénoïque (DHA) est supérieure ou égale à 0,018 g pour 100 g, 100 ml ou 100 kcal ,